Pentwater Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Hold |
|
|||||
|
2025
Q1 | $261K | Hold |
|
|||||
|
2024
Q4 | $399K | Hold |
|
|||||
|
2024
Q3 | $299K | Hold |
|
|||||
|
2024
Q2 | $402K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $252K | Hold |
|
|||||
|
2023
Q1 | $288K | Buy |
|
|||||
|
2022
Q4 | $873K | Sell |
|
|||||
|
2022
Q3 | $1.71M | Sell |
|
|||||
|
2022
Q2 | $2.06M | Sell |
|
|||||
|
2022
Q1 | $1.66M | Sell |
|
|||||
|
2021
Q4 | $1.81M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $6.12M | Sell |
|
|||||
|
2021
Q1 | $17M | Buy |
|
|||||
|
2020
Q4 | $12.9M | Sell |
|
|||||
|
2020
Q3 | $80.6M | Sell |
|
|||||
|
2020
Q2 | $115M | Sell |
|
|||||
|
2020
Q1 | $72.9M | Buy |
|
|||||
|
2019
Q4 | $134M | Sell |
|
|||||
|
2019
Q3 | $90.9M | Buy |
|
|||||
|
2019
Q2 | $113M | Sell |
|
|||||
|
2019
Q1 | $99.4M | Sell |
|
|||||
|
2018
Q4 | $114M | Buy |
|
|||||
|
2018
Q3 | $104M | Sell |
|
|||||
|
2018
Q2 | $96.6M | Buy |
|
|||||
|
2018
Q1 | $167M | Buy |
|
|||||
|
2017
Q4 | $127M | Sell |
|
|||||
|
2017
Q3 | $112M | Buy |
|
|||||
|
2017
Q2 | $92M | Buy |
|
|||||
|
2017
Q1 | $64.8M | Buy |
|
|||||
|
2016
Q4 | $22.9M | Buy |
|
|||||
|
2016
Q3 | $21.3M | Buy |
|
|||||
|
2016
Q2 | $15M | Buy |
|
|||||
|
2016
Q1 | $24.1M | Sell |
|
|||||
|
2015
Q4 | $32M | Sell |
|
|||||
|
2015
Q3 | $34.2M | Sell |
|
|||||
|
2015
Q2 | $124M | Buy |
|
|||||
|
2015
Q1 | $120M | Sell |
|
|||||
|
2014
Q4 | $59.4M | Buy |
|
|||||
|
2014
Q3 | $24.2M | Sell |
|
|||||
|
2014
Q2 | $15.8M | Buy |
|
|||||
|
2014
Q1 | $13.4M | Buy |
|
|||||
|
2013
Q4 | $8.82M | Buy |
|
|||||
|
2013
Q3 | $8.13M | Buy |
|